ML-364

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameML-364
Drug Alias NameML-364
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-specific protease 2 inhibitors
TargetsUbiquitin-specific protease 2
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A